{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:19:00Z","timestamp":1783127940467,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002635","name":"Inha University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016257","name":"Inha University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.rmed.2025.107939","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T17:19:23Z","timestamp":1735838363000},"page":"107939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Association between calcium channel blocker use and the risk of interstitial lung disease and idiopathic pulmonary fibrosis: A longitudinal cohort study"],"prefix":"10.1016","volume":"237","author":[{"given":"Hye Jin","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Min","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-9975","authenticated-orcid":false,"given":"Jihyeon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Young","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-7859","authenticated-orcid":false,"given":"Jin-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7705-0098","authenticated-orcid":false,"given":"Won-Il","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"150","key":"10.1016\/j.rmed.2025.107939_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur. Respir. Rev."},{"issue":"10","key":"10.1016\/j.rmed.2025.107939_bib2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1164\/rccm.201903-0486OC","article-title":"Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort","volume":"200","author":"Hoffmann-Vold","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.107939_bib3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/bph.14939","article-title":"Ca2+ signalling in fibroblasts and the therapeutic potential of KCa3. 1 channel blockers in fibrotic diseases","volume":"177","author":"Roach","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.rmed.2025.107939_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","author":"Bonner","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.rmed.2025.107939_bib5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/09031936.00152106","article-title":"Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis","volume":"29","author":"Chaudhary","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.107939_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1385\/IR:30:3:339","article-title":"Therapeutic targeting of IL-4-and IL-13-responsive cells in pulmonary fibrosis","volume":"30","author":"Jakubzick","year":"2004","journal-title":"Immunol. Res."},{"issue":"2","key":"10.1016\/j.rmed.2025.107939_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000073718","article-title":"Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro","volume":"132","author":"Saito","year":"2003","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2025.107939_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02533-2020","article-title":"Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease","volume":"57","author":"Matson","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2025.107939_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1164\/rccm.202103-0569OC","article-title":"Lung microenvironments and disease progression in fibrotic hypersensitivity pneumonitis","volume":"205","author":"De Sadeleer","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.107939_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00692-2018","article-title":"What's in a name? That which we call IPF, by any other name would act the same","volume":"51","author":"Wells","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2025.107939_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1165\/rcmb.2014-0269TR","article-title":"Calcium homeostasis and ionic mechanisms in pulmonary fibroblasts","volume":"53","author":"Janssen","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.rmed.2025.107939_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1165\/rcmb.2015-0009OC","article-title":"Disruption of calcium signaling in fibroblasts and attenuation of bleomycin-induced fibrosis by nifedipine","volume":"53","author":"Mukherjee","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.rmed.2025.107939_bib13","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1038\/s41598-017-03676-y","article-title":"Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice","volume":"7","author":"Tanaka","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2025.107939_bib14","series-title":"Calcium Channel Blockers and Cardiovascular Outcomes: a Meta-Analysis of 175 634 Patients","first-page":"1136","author":"Costanzo","year":"2009"},{"issue":"9","key":"10.1016\/j.rmed.2025.107939_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016640","article-title":"Cohort profile: the national health insurance service-national health screening cohort (NHIS-heals) in Korea","volume":"7","author":"Seong","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.rmed.2025.107939_bib16","article-title":"The defined daily dose system (DDD) for drug utilization review","volume":"21","author":"Wertheimer","year":"1986","journal-title":"Hosp. Pharm."},{"issue":"8","key":"10.1016\/j.rmed.2025.107939_bib17","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ki.2008.328","article-title":"Survival analysis: time-dependent effects and time-varying risk factors","volume":"74","author":"Dekker","year":"2008","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.rmed.2025.107939_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00291-2023","article-title":"Association between the use of statins and risk of interstitial lung disease\/idiopathic pulmonary fibrosis: time-dependent analysis of population-based nationwide data","volume":"62","author":"Jang","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2025.107939_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1189\/jlb.2MR1114-573R","article-title":"Store-operated calcium signaling in neutrophils","volume":"98","author":"Clemens","year":"2015","journal-title":"Journal of Leucocyte Biology"},{"issue":"2","key":"10.1016\/j.rmed.2025.107939_bib20","first-page":"485","article-title":"Cytosolic Ca2+ signalling in inflammatory neutrophils: implications for rheumatoid arthritis","volume":"1","author":"Davies","year":"1998","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.rmed.2025.107939_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12964","article-title":"Calcium signalling and related ion channels in neutrophil recruitment and function","volume":"48","author":"Immler","year":"2018","journal-title":"Eur. J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.rmed.2025.107939_bib22","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/liv.12681","article-title":"K+\u2010channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells","volume":"35","author":"Freise","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.rmed.2025.107939_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00232-007-0027-8","article-title":"Contribution of BK Ca-channel activity in human cardiac fibroblasts to electrical coupling of cardiomyocytes-fibroblasts","volume":"213","author":"Wang","year":"2006","journal-title":"J. Membr. Biol."},{"issue":"2","key":"10.1016\/j.rmed.2025.107939_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ndt\/gft431","article-title":"KCa3. 1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis","volume":"29","author":"Huang","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.rmed.2025.107939_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.anai.2021.02.029","article-title":"Inhibitory effect of calcium channel blockers on the deterioration of lung function in adult-onset asthma","volume":"126","author":"Tsuzuki","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"7","key":"10.1016\/j.rmed.2025.107939_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11071974","article-title":"Calcium Channel blockers and the risk of exacerbation in patients with chronic obstructive pulmonary disease: a nationwide study of 48,488 outpatients","volume":"11","author":"Rastoder","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.rmed.2025.107939_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10641960903254414","article-title":"Anti-inflammatory properties of azelnidipine, a dihydropyridine-based calcium channel blocker","volume":"32","author":"Komoda","year":"2010","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.rmed.2025.107939_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-024-02989-w","article-title":"Anti-inflammatory activity of benidipine hydrochloride in LPS-activated mammalian macrophages","author":"Servi","year":"2024","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2025.107939_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.2008.103382","article-title":"Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis","volume":"69","author":"Allanore","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl A","key":"10.1016\/j.rmed.2025.107939_bib30","doi-asserted-by":"crossref","first-page":"A71","DOI":"10.1093\/eurheartj\/18.suppl_A.71","article-title":"Pharmacological differences between calcium antagonists","volume":"18","author":"Opie","year":"1997","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2025.107939_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.rmed.2025.107939_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113236","article-title":"Application of glucagon-like peptide-1 receptor antagonists in fibrotic diseases","volume":"152","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:25:49Z","timestamp":1740356749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":32,"alternative-id":["S0954611125000010"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.107939","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between calcium channel blocker use and the risk of interstitial lung disease and idiopathic pulmonary fibrosis: A longitudinal cohort study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.107939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107939"}}